Table 3 Baseline values of questionnaires scores. Means were compared between balneotherapy and control groups
From: Balneotherapy for the treatment of post-COVID syndrome: a randomized controlled trial
Balneotherapy | Control group | p-value | |
|---|---|---|---|
N=51 | N=47 | ||
Mean (SD) | Mean (SD) | ||
PCFS | 2.55 (0.67) | 2.51 (0.66) | 0.732 |
mMRC Dyspnoea Scale | 1.75 (0.73) | 1.44 (0.84) | 0.060 |
SF-36 | |||
•Physical functioning | 44.9 (17.16) | 51.44 (21.83) | 0.102 |
•Role limitations due to physical health | 21.04 (21.46) | 28.93 (23.02) | 0.087 |
•Role limitations due to emotional problems | 62.23 (28.5) | 56.1 (23.2) | 0.258 |
•Energy/fatigue | 15.9 (14.66) | 24.33 (19.93) | 0,051 |
•Emotional well-being | 58.17 (19.57) | 50.66 (20.85) | 0.071 |
•Social functioning | 37.26 (22.88) | 35.55 (21.64) | 0.709 |
•Pain | 23.33 (19.74) | 30.55 (23.91) | 0,109 |
•General health | 34.13 (14.8) | 33.66 (15.27) | 0.879 |
PSQI | 11.86 (4.21) | 11.13 (4,17) | 0.394 |
HADS | |||
•Anxiety | 8.27 (4.08) | 9.82 (5.28) | 0.106 |
•Depression | 9.42 (4.4) | 9.95 (4.12) | 0.542 |
MFE-30 | 53.65 (25.64) | 48.28 (28.58) | 0.332 |
VAS | 5.67 (2.17) | 5.05 (2.72) | 0.221 |